Literature DB >> 17384314

Predictive validity of neuropsychiatric subgroups on nursing home placement and survival in patients with Alzheimer disease.

Saw-Myo Tun1, Daniel L Murman, Heidi L Long, Christopher C Colenda, Alexander von Eye.   

Abstract

OBJECTIVE: The aim of the study was to conceptualize neuropsychiatric symptoms in patients with Alzheimer disease as distinct symptom profiles with differential disease outcomes. Two outcomes of interest in the study were nursing home placement and survival.
METHOD: Cluster analysis was used to categorize 122 patients with Alzheimer disease based on their neuropsychiatric symptoms as assessed by the Neuropsychiatric Inventory. Both the presence as well as the severity and frequency of symptoms were considered. After identification of the subgroups, the predictive validity of the categorization was tested on time to nursing home placement and time to death over a three-year period. Cox proportional hazard models were used to perform survival analysis. Important covariates such as severity of cognitive and functional impairments, comorbid medical conditions, presence of parkinsonism, and marital status were adjusted at baseline.
RESULTS: Based on the presence of neuropsychiatric symptoms, three subgroups were identified: minimally symptomatic, highly symptomatic, and affective/apathetic. Over a three-year period, the highly symptomatic group had an increased risk of nursing home placement. In addition, the rates of survival were significantly lower for the highly symptomatic and the affective/apathetic subgroups. Based on the severity and frequency of symptoms, two-cluster and four-cluster solutions were produced. The groupings based on severity and frequency of symptoms predicted significant differential outcomes in survival and nursing home placement.
CONCLUSIONS: Neuropsychiatric subgroups were able to predict differential outcomes and identify those with an increased risk for a worse prognosis. The findings were discussed through their research and clinical implications.

Entities:  

Mesh:

Year:  2007        PMID: 17384314     DOI: 10.1097/01.JGP.0000239263.52621.97

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  26 in total

1.  Neuropsychiatric symptoms in severe dementia: Associations with specific cognitive domains the Cache County Dementia Progression Study.

Authors:  William J Rozum; Bryce Cooley; Elizabeth Vernon; Joshua Matyi; JoAnn T Tschanz
Journal:  Int J Geriatr Psychiatry       Date:  2019-04-25       Impact factor: 3.485

2.  Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.

Authors:  Donovan T Maust; Hyungjin Myra Kim; Lisa S Seyfried; Claire Chiang; Janet Kavanagh; Lon S Schneider; Helen C Kales
Journal:  JAMA Psychiatry       Date:  2015-05       Impact factor: 21.596

3.  Characteristics of Activities for Persons With Dementia at the Mild, Moderate, and Severe Stages.

Authors:  Natalie G Regier; Nancy A Hodgson; Laura N Gitlin
Journal:  Gerontologist       Date:  2017-10-01

Review 4.  Management of Behavioral and Psychological Symptoms of Dementia.

Authors:  Eylem Şahin Cankurtaran
Journal:  Noro Psikiyatr Ars       Date:  2014-12-01       Impact factor: 1.339

5.  Nomenclature Used by Family Caregivers to Describe and Characterize Neuropsychiatric Symptoms.

Authors:  Andrea Gilmore-Bykovskyi; Shannon Mullen; Laura Block; Abigail Jacobs; Nicole E Werner
Journal:  Gerontologist       Date:  2020-07-15

6.  Neuropsychiatric symptoms in dementia patients with and without a history of traumatic brain injury.

Authors:  Vani Rao; Paul Rosenberg; Quincy Samus Miles; Deepa Patadia; Kate Treiber; Melaine Bertrand; Maria Norton; Martin Steinberg; JoAnn Tschanz; Constantine Lyketsos
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

7.  Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer's disease: a UK evaluation using discrete-event simulation.

Authors:  Denis Getsios; Steve Blume; K Jack Ishak; Grant D H Maclaine
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

8.  Patient death as a censoring event or competing risk event in models of nursing home placement.

Authors:  Jeff M Szychowski; David L Roth; Olivio J Clay; Mary S Mittelman
Journal:  Stat Med       Date:  2010-02-10       Impact factor: 2.373

9.  Outcome measures for Parkinson's disease dementia: a systematic review.

Authors:  Samantha K Holden; Wallace E Jones; Keith A Baker; Isabel M Boersma; Benzi M Kluger
Journal:  Mov Disord Clin Pract       Date:  2015-09-16

10.  Total cholesterol and neuropsychiatric symptoms in Alzheimer's disease: the impact of total cholesterol level and gender.

Authors:  James R Hall; April R Wiechmann; Leigh A Johnson; Melissa Edwards; Robert C Barber; Rebecca Cunningham; Meharvan Singh; Sid E O'Bryant
Journal:  Dement Geriatr Cogn Disord       Date:  2014-07-04       Impact factor: 2.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.